U.S. market Closed. Opens in 1 hour 21 minutes

ZJYL | Jin Medical International Ltd. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for ZJYL we got that it has average fundamentals where Valuation is considered to be slightly overvalued, Profitability is wealthy, Growth is bad and Health is strong.

Valuation (48%)

Company Industry
P/E Ratio (TTM) 39.76 49.50
PEG Ratio (TTM) -0.44 4.50
P/S Ratio (TTM) 5.53 13.78
P/B Ratio (TTM) 5.25 7.34
P/FCF Ratio (TTM) 386.69 229.30
Price to 5YR AVG Earnings Ratio 2.45 105.54
Price to 5YR AVG FCF Ratio 60.99 97.57

Profitability (65%)

Company Industry
ROA (TTM) 8.41% 6.72%
ROE (TTM) 13.79% 11.28%
Net Profit Margin (TTM) 13.90% -0.16%
ROIC 5YR AVG 22.01% 11.39%

Growth (43%)

4QTR AVG 3YR AVG 5YR AVG
EPS -5.23% 1,626.24% 957.52%
Revenue 0.46% 1.71% 0.17%
Net Income 3.04% -7.05% -2.39%
Cash Flow -21.62% 155.64% 98.10%

Health (63%)

Company Industry
Current Ratio (TTM) 2.58 3.26
Quick Ratio (TTM) 2.15 2.48
D/E Ratio (TTM) 0.37 0.51
Interest Coverage (TTM) N/A 39.67
Piotroski F-Score 6 6
Altman Z-Score 7.82 27.26
LTL to 5YR AVG FCF N/A 4.14
Shares Outstanding Growth 5YR AVG 323.25% 0.91%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙